Literature DB >> 17111425

Intraoral proliferative myositis: case report and literature review.

John K Brooks1, Mark A Scheper, Richard E Kramer, John C Papadimitriou, John J Sauk, Nikolaos G Nikitakis.   

Abstract

BACKGROUND: Proliferative myositis is a rare, benign, reactive intramuscular lesion of fibroblastic/myofibroblastic origin; an identical lesion in a subcutaneous or fascial location is referred to as proliferative fasciitis. The rapid growth rate and unusual histopathologic features have frequently been mistaken for a malignant process and have promoted unnecessary invasive procedures. Here we present only the third oral case of proliferative myositis, arising from the tongue of a 65-year-old man. METHODS AND
RESULTS: Histologically, the resected lesion was composed of numerous fibroblastic or myofibroblastic spindle cells and variable numbers of large ganglion-like cells infiltrating between and around muscle fascicles, resembling a "checkerboard" configuration. A demographic profile of proliferative myositis of the head and neck is also provided, compiled from 19 patients culled from an English-language literature review and this report.
CONCLUSIONS: Incisional biopsy or fine-needle aspiration biopsy of proliferative myositis of the head and neck should lead to spontaneous resolution and is, therefore, sufficient to render the diagnosis and to provide conservative treatment. Recurrence is extremely rare. (c) 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17111425     DOI: 10.1002/hed.20530

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  The first case of proliferative fasciitis of tongue coexistent with squamous cell carcinoma: Case report of a rare lesion.

Authors:  Vaishali Baburao Nagose; Vikrant Vilas Vaze; Neha Amrut Mahajan; Vipin Narendra Todase
Journal:  J Oral Maxillofac Pathol       Date:  2022-03-31

2.  Proliferative myositis in the right brachioradialis: A case report.

Authors:  Na Wei; Wei-Jie Xu; Dong Dong; Yu-Bao Gong
Journal:  Exp Ther Med       Date:  2017-03-28       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.